Norden Group LLC Grows Position in UnitedHealth Group Incorporated (NYSE:UNH)

Norden Group LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2,171.0% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 100,149 shares of the healthcare conglomerate’s stock after purchasing an additional 95,739 shares during the period. Norden Group LLC’s holdings in UnitedHealth Group were worth $49,547,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Tealwood Asset Management Inc. boosted its holdings in shares of UnitedHealth Group by 0.4% in the fourth quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock valued at $2,626,000 after purchasing an additional 19 shares during the period. Atlas Private Wealth Advisors boosted its holdings in shares of UnitedHealth Group by 1.1% in the fourth quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock valued at $923,000 after purchasing an additional 19 shares during the period. Prentice Wealth Management LLC lifted its holdings in UnitedHealth Group by 0.8% during the fourth quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock worth $1,235,000 after buying an additional 19 shares during the period. Baker Avenue Asset Management LP lifted its holdings in UnitedHealth Group by 1.7% during the third quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock worth $615,000 after buying an additional 20 shares during the period. Finally, Granite Harbor Advisors Inc. lifted its holdings in UnitedHealth Group by 2.9% during the third quarter. Granite Harbor Advisors Inc. now owns 718 shares of the healthcare conglomerate’s stock worth $362,000 after buying an additional 20 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 1.7 %

Shares of UnitedHealth Group stock opened at $489.90 on Thursday. The firm has a market capitalization of $450.90 billion, a PE ratio of 29.94, a P/E/G ratio of 1.47 and a beta of 0.60. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The firm’s 50-day moving average price is $498.64 and its 200 day moving average price is $501.12. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same period last year, the company posted $6.26 EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.55 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.71%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date of this dividend was Monday, June 17th. UnitedHealth Group’s dividend payout ratio (DPR) is 51.34%.

Analysts Set New Price Targets

UNH has been the subject of several analyst reports. JPMorgan Chase & Co. increased their price objective on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. Morgan Stanley cut their target price on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research report on Friday, April 5th. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Baird R W raised UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Finally, Truist Financial reissued a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Three investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $579.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.